Follow us on

Our blog

Jun 06, 2026

Journal Watch: Ultrasound-Guided Fasciotomy for Chronic Exertional Compartment Syndrome

Can Chronic Exertional Compartment Syndrome Be Treated Through Tiny Incisions Using Ultrasound Guidance?

Chronic Exertional Compartment Syndrome (CECS) remains one of the more frustrating causes of exercise-induced leg pain in athletes. While traditional surgical fasciotomy is generally effective, it requires operating room resources, larger incisions, and often several weeks before return to unrestricted activity.

A study by Lueders and colleagues published in PM&R explored an intriguing question: Can compartment release be performed safely and effectively using ultrasound guidance through tiny percutaneous incisions rather than traditional surgery?

What is Chronic Exertional Compartment Syndrome (CECS)?

CECS occurs when pressure builds within a muscle compartment during exercise, resulting in pain, tightness, weakness, numbness, or loss of performance. There are five cardinal symptoms of CECS, including pain, tightness, cramping, weakness, and paresthesia, and the symptoms classically occur during exertion and resolve with cessation of activity (Ding et al, 2020).

A systematic review confirmed that CECS is an overuse injury typically seen in young and athletic patients, with studied populations including military servicemen, motocross racers, and other athletes (Ding et al, 2020).

Traditional surgical fasciotomy demonstrated good outcomes but is associated with complications and recovery periods often ranging from 6 to 12 weeks.

  • One systematic review reported complication rates including hematomas (2.7%–22.5%), nerve injuries (2.0%–18.6%), DVT (2.7%), and symptom recurrence (0.65%–8.4%), with up to 10.4% of patients requiring revision fasciotomy (Ding et al, 2020).
  • "Recovery" after traditional fasciotomy varies depending on the milestone measured:
    • Return to running: Median of 21 days (Detmer et al, 1985).
    • Return to Sport: Mean time to return to sport (RTS) has also been reported as 5.5 ± 6.1 months in a study with 6-year mean follow-up, though this wide standard deviation reflects significant variability among patients. In this study, the best patient-perceived outcome was reported at a mean of 14.3 months (range 0.5–84 months), suggesting that full functional optimization maytake considerably longer than initial return to activity (Pasic et al, 2015; Moore et al, 2025).

The search for less invasive treatment options has led investigators to explore ultrasound-guided techniques that may allow compartment release through significantly smaller incisions.

What does this study teach us about future treatment options for CECS?

In the Lueders et al. study, the authors performed a cadaveric feasibility study evaluating ultrasound-guided fasciotomy of the anterior and lateral leg compartments.

Using a specialized 3-mm meniscotome and real-time ultrasound guidance, two experienced physicians performed 20 compartment releases in 10 unembalmed cadaveric lower extremities. Following each procedure, detailed dissections were performed to evaluate:

  • Completeness of the fasciotomy
  • Length of fascial release
  • Injury to surrounding nerves and blood vessels
  • Damage to adjacent tissues

The primary question was simple: Could a meaningful compartment release be achieved safely through a minimally invasive ultrasound-guided approach?

Key Findings included:

No Neurovascular Injuries

Perhaps the most important finding was that none of the 20 procedures resulted in injury to major nerves or blood vessels. This highlights one of the major theoretical advantages of ultrasound-guided procedures: the ability to directly visualize and avoid critical structures throughout the procedure.

Successful Fascial Release Length

All 20 procedures achieved the intended fascial release length.

The average fasciotomy measured 22.5 cm, which is comparable to release lengths reported with traditional surgical approaches. This suggests that a percutaneous technique may be capable of achieving a clinically meaningful decompression.

Continuous Release Achieved in Most Cases

A continuous fascial release was achieved in 65% of procedures.

In the remaining cases, small intact fascial bands remained, averaging approximately 1.5 cm in length. Whether these residual bands would affect clinical outcomes remains unknown and represents one of the major unanswered questions arising from this study.

What Makes Ultrasound Guidance Different?

One of the most compelling aspects of this study is the role of ultrasound itself. Traditional surgery relies on direct visualization through an open incision. Ultrasound-guided procedures instead provide real-time imaging beneath the skin, allowing physicians to visualize:

  • The compartment fascia
  • Superficial peroneal nerve
  • Deep peroneal nerve
  • Common peroneal nerve
  • Blood vessels
  • Adjacent muscles

This ability to "see through the skin" enables targeted treatment while minimizing disruption of surrounding tissues. For many musculoskeletal procedures, ultrasound guidance has already demonstrated improved procedural accuracy and reduced complications.

The concept of applying these same principles to compartment release is a logical next step.

Clinical Implications

Although this was not a patient study, it demonstrates the technical feasibility of performing compartment release through two 3-mm incisions using ultrasound guidance.

Advantages include:

  • Office-based treatment
  • Local anesthesia rather than regional or general anesthesia
  • Smaller incisions
  • Reduced soft tissue trauma
  • Faster rehabilitation
  • Earlier return to sport
  • Lower healthcare costs

These are meaningful potential advantages for athletes seeking to return to training and competition as quickly as possible.

Ultrasound-guided compartment release offers a compelling vision for the future: precise fascial release performed through tiny incisions under real-time imaging guidance.

The findings demonstrate that ultrasound-guided fasciotomy is technically feasible and can be performed without neurovascular injury in a cadaveric model. As ultrasound-guided surgery continues to expand across musculoskeletal medicine, CECS may become another condition where image-guided procedures provide an effective alternative to traditional surgical approaches.


Boston Sports & Biologics

(781) 591-7855

info@BSBortho.com

20 Walnut St

Suite 14

Wellesley MA 02481

References

  1. Detmer DE, Sharpe K, Sufit RL, Girdley FM. Chronic compartment syndrome: diagnosis, management, and outcomes. Am J Sports Med. 1985 May-Jun;13(3):162-70. doi: 10.1177/036354658501300304. PMID: 4014531.
  2. Ding A, Machin M, Onida S, Davies AH. A systematic review of fasciotomy in chronic exertional compartment syndrome. J Vasc Surg. 2020 Nov;72(5):1802-1812. doi: 10.1016/j.jvs.2020.05.030. Epub 2020 May 27. PMID: 32473344.
  3. Lueders DR, Sellon JL, Smith J, Finnoff JT. Ultrasound-Guided Fasciotomy for Chronic Exertional Compartment Syndrome: A Cadaveric Investigation. PM R. 2017 Jul;9(7):683-690. doi: 10.1016/j.pmrj.2016.09.002. Epub 2016 Sep 14. PMID: 27639651.
  4. Moore M, Lezak B, Berzolla E, Hughes A, Seidenberg J, Kaplan D, Strauss E, Jazrawi L. Medium- to Long-term Outcomes of Fasciotomy for Chronic Exertional Compartment Syndrome: A 6-Year Mean Follow-up Study. Sports Health. 2025 Sep-Oct;17(5):958-964. doi: 10.1177/19417381241288899. Epub 2024 Oct 21. PMID: 39434455; PMCID: PMC11556667.
  5. Pasic N, Bryant D, Willits K, Whitehead D. Assessing outcomes in individuals undergoing fasciotomy for chronic exertional compartment syndrome of the leg. Arthroscopy. 2015 Apr;31(4):707-713.e5. doi: 10.1016/j.arthro.2014.10.018. Epub 2014 Dec 25. PMID: 25543245.

More Articles

Jun 06, 2026

Journal Watch: Ultrasound-Guided Fasciotomy for Chronic Exertional Compartment Syndrome

A new PM&R study evaluates ultrasound-guided fasciotomy for chronic exertional compartment syndrome (CECS), highlighting a promising minimally invasive treatment approach.

Read More
May 31, 2026

Wharton's Jelly and Umbilical Cord "Stem Cell" Products: What Patients Need to Know

The FDA has repeatedly stated that most Wharton's Jelly, exosome, and umbilical cord-derived products marketed as regenerative medicine treatments are unapproved biologic drugs. Current evidence suggests these products

Read More